Medicine
Colistimethate 150 mg powder for injection
Colistimethate 150 mg powder for injection is a generic prescription medicine for intramuscular, intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store between 20° to 25°C (68° to 77°F). Store reconstituted solution in…
Key facts
- Active ingredient (INN)
- Colistimethate
- Brand
- Sold under the generic name
- Strength
- 150 mg
- Dosage form
- Powder for injection
- Route
- Intramuscular, intravenous
- Packs
- 1 vial, 12 vials and 2 more
- Manufacturers
- Xellia PharmaceuticalsHikma Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store between 20° to 25°C (68° to 77°F). Store reconstituted solution in refrigerator 2° to 8°C (36° to 46°F) or between 20° to 25°C (68° to 77°F), and use within 7 days.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01XB01 Colistimethate
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 October 2018
- Identifiers
- RxCUI 1117522DailyMed set ID 13dc3525-1879-4bd8-a922-81bc1397d5af, 8ec7dc90-825c-422e-9f4b-c8ace9d93af5, bf556f89-6373-45cb-b465-d991fde7eab9NDC 70594-023, 0143-9443Application ANDA205356
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, glass in 1 vial / 1 injection, powder, for solution in 1 vial, glass | 70594-023-01 | Xellia Pharmaceuticals | 1 October 2018 |
| 12 vial, glass in 1 carton / 1 injection, powder, for solution in 1 vial, glass | 70594-023-04 | Xellia Pharmaceuticals | 1 October 2018 |
| 1 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 70594-023-09 | Xellia Pharmaceuticals | 20 February 2022 |
| 1 vial, glass in 1 carton / 1 injection, powder, for solution in 1 vial, glass | 0143-9443-01 | Hikma Pharmaceuticals | 4 March 2026 |
| 12 vial, glass in 1 carton / 1 injection, powder, for solution in 1 vial, glass | 0143-9443-12 | Hikma Pharmaceuticals | 4 March 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Colistimethate
Clinical summary
Colistimethate is a polymyxin-class antibacterial indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, among other approved uses. MedsAcross supplies Colistimethate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ColistimethateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Coly-Mycin M prescribing information (Par Health) · U.S. National Library of Medicine, DailyMed
- Colobreathe: European public assessment report (EPAR) · European Medicines Agency
Need Colistimethate 150 mg powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.